Compare Trade Desk Inc (TTD) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Trade Desk Inc vs Zimmer Biomet Holdings Inc — how do they compare? Trade Desk Inc trades at $13.9 (market cap $6.59B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $17.97B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 2.7× Trade Desk Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.02% dividend while Trade Desk Inc pays none. Which is the better fit depends on your goals.
| TTD | ZBH | |
|---|---|---|
Market Cap | $6.59B | $17.97B |
Sector | Technology | Health |
52-Week High | $54.13 | $104.26 |
52-Week Low | $13.03 | $79.58 |
Enterprise Value | $5.54B | $25.04B |
Dividend Yield | — | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The Trade Desk (TTD) trades at $14.02, down 2.84% on the day and near its 52-week lows, reflecting significant year-to-date pressure. Recent financials show revenue growth slowing to 3% in Q2 2026 with earnings misses, while the company undergoes a 15% workforce restructuring. Technical indicators signal a bearish trend with mixed momentum oscillators. Despite strong profitability margins, valuation multiples remain compressed amid weak advertising demand and competitive pressures.
Outlook remains cautious with near-term headwinds from soft ad spending and execution risks from restructuring. Long-term opportunities exist in CTV and AI-driven ad platforms, but investor sentiment is divided with analysts showing mixed ratings. The stock trades below consensus price targets, offering potential upside if operational improvements materialize, though volatility may persist.
Zimmer Biomet (ZBH) trades at $94.22, down 3.93% on the day, with a bearish technical signal but strong fundamentals including a 69.87% gross margin and three consecutive quarterly earnings beats. Revenue growth is steady, reaching $8.23B in 2025, though net income margin dipped to 8.56%. Recent leadership promotions aim to accelerate commercial transformation, while analyst consensus price target is $104.88, implying 11.3% upside.
The stock presents a value opportunity with a P/E of 22.87 and P/S of 2.17, supported by robust cash flow and dividend payments. Risks include rising debt-to-asset ratio (32.57% in 2025) and competitive pressures. Wall Street sentiment is mixed with 40.48% buy ratings, but technical indicators suggest near-term caution amid bearish moving averages.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
